More guidance on using the COVID-19 drug Paxlovid

Guidelines advise unvaccinated people at high risk for severe COVID to take Paxlovid (nirmatrelvir with ritonavir) soon after symptoms begin. However, a 2024 study suggests that people who are vaccinated and high-risk or unvaccinated and low-risk don’t need to do so.